Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine vs Haloperidol in Hyperactive Delirium
NCT05690698Phase 3Completed
- Sponsor
- Alexandria University
- Start
- Apr 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in delirium, sponsored by Alexandria University. Started Apr 2023; status: completed.
02
Drugs
quetiapine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT05690698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05690698.